NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Clinical trials for NON-MUSCLE INVASIVE BLADDER NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new NON-MUSCLE INVASIVE BLADDER NEOPLASMS trials appear
Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New targeted therapy aims to keep bladder cancer from returning
Disease control Recruiting nowThis study compares a new drug delivery system, TAR-210, to standard chemotherapy for people with a certain type of bladder cancer that hasn't spread into the muscle. The TAR-210 system delivers erdafitinib directly into the bladder, targeting tumors with specific genetic changes…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 06:30 UTC
-
New bladder cancer treatment delivers drug directly to tumor
Disease control Recruiting nowThis study is testing a new treatment for bladder cancer that places a special device (TAR-210) directly into the bladder to release the drug erdafitinib. The goal is to find the best dose and see if it can shrink or eliminate tumors while keeping side effects manageable. About 2…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 26, 2026 06:23 UTC
-
New combo therapy aims to keep bladder cancer from coming back
Disease control Recruiting nowThis study tests whether adding an experimental drug (V940) to standard BCG immunotherapy can help people with high-risk non-muscle invasive bladder cancer live longer without their cancer returning or spreading. About 308 adults who have not had BCG before will be randomly assig…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New injection targets bladder tumors in early trial
Disease control Recruiting nowThis early-stage trial is testing a new drug called belzupacap sarotalocan (AU-011) for people with a type of bladder cancer that hasn't spread into the muscle layer. The drug is injected directly into the tumor, sometimes with a laser, to see if it's safe and possible to do. Abo…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE1 • Sponsor: Aura Biosciences • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New bladder cancer treatment tracked in Real-World study
Disease control Recruiting nowThis study follows 150 people with early-stage bladder cancer (NMIBC) who are receiving a treatment called TAR-200. Researchers want to see how long it takes for the cancer to come back or get worse in real-world settings. The goal is to understand how well TAR-200 works outside …
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New targeted therapy aims to keep bladder cancer from returning
Disease control Recruiting nowThis study tests a new treatment called TAR-210 (a drug placed directly into the bladder) against standard chemotherapy for people with a high-risk type of bladder cancer that has certain genetic changes (FGFR alterations). Participants have already received BCG therapy. The goal…
Matched conditions: NON-MUSCLE INVASIVE BLADDER NEOPLASMS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 19, 2026 11:47 UTC